Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

SHE:300452 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Equivalents	269.88	299.42	192.69	173.96	150.12	141.26
Trading Asset Securities	588.66	521.55	515.63	511.77	214.56	187.88
Cash & Short-Term Investments	858.55	820.97	708.32	685.73	364.68	329.14
Cash Growth	21.32%	15.90%	3.29%	88.03%	10.80%	9.55%
Accounts Receivable	248.16	221.92	204.73	145.57	123.39	129.53
Other Receivables	0.89	0.64	1.05	0.59	0.59	0.26
Receivables	249.06	222.56	205.78	146.16	123.98	129.79
Inventory	108.38	92.26	88.76	94.1	91.2	77.77
Other Current Assets	15.91	15.99	18.67	13.37	51.46	16.12
Total Current Assets	1,232	1,152	1,022	939.37	631.32	552.82
Property, Plant & Equipment	491.39	496.19	476.45	503.57	439.83	305.04
Goodwill	-	-	-	39.13	39.13	39.13
Other Intangible Assets	54.28	54.99	51.22	52.37	53.66	54.48
Long-Term Deferred Tax Assets	4.69	4.66	5.96	5.97	12.66	8.13
Long-Term Deferred Charges	2.91	3.51	2.19	1.6	0.98	0.46
Other Long-Term Assets	3.17	1.77	2.37	0.71	2.97	2.52
Total Assets	1,788	1,713	1,560	1,543	1,181	962.58

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Accounts Payable	250.46	219.26	186.09	219.23	225.95	132.26
Accrued Expenses	11.3	21.42	17.74	17.74	14.74	12.48
Short-Term Debt	31.51	5.52	6.46	10.01	39.84	31.04
Current Income Taxes Payable	6.07	11.27	0.02	4.07	0.04	3.12
Current Unearned Revenue	8.49	8.02	7.09	6.82	22.58	11.45
Other Current Liabilities	14.52	12.76	16.07	15.49	42.1	32.92
Total Current Liabilities	322.35	278.26	233.47	273.36	345.25	223.26
Long-Term Debt	314.18	309.19	298.51	287.59	-	-
Long-Term Unearned Revenue	32.68	34.97	33.49	35	31.13	27.76
Long-Term Deferred Tax Liabilities	16.43	16.78	18.95	11.51	15.56	5.64
Total Liabilities	685.64	639.2	584.43	607.46	391.93	256.67

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Common Stock	234.46	234.45	234.45	234.46	234.52	180.47
Additional Paid-In Capital	65.61	65.54	65.51	65.58	65.81	65.64
Retained Earnings	725.32	698.92	592.15	530.88	427.94	405.45
Treasury Stock	-22.51	-22.51	-22.51	-0.21	-5.83	-12.13
Comprehensive Income & Other	31.79	30.25	35.41	35.39	0.07	0.57
Total Common Equity	1,035	1,007	905.01	866.09	722.52	640
Minority Interest	68.03	67.04	70.29	69.15	66.1	65.92
Shareholders' Equity	1,103	1,074	975.3	935.25	788.62	705.92
Total Liabilities & Equity	1,788	1,713	1,560	1,543	1,181	962.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Total Debt	345.69	314.71	304.98	297.6	39.84	31.04
Net Cash (Debt)	512.86	506.26	403.35	388.13	324.84	298.11
Net Cash Growth	29.16%	25.51%	3.92%	19.48%	8.97%	14.45%
Net Cash Per Share	2.11	2.09	1.72	1.61	1.39	1.27
Filing Date Shares Outstanding	232.63	232.63	232.62	237.2	223.93	237.49
Total Common Shares Outstanding	232.63	232.63	232.62	237.2	223.93	237.49
Working Capital	909.54	873.51	788.06	666.01	286.07	329.56
Book Value Per Share	4.45	4.33	3.89	3.65	3.23	2.69
Tangible Book Value	980.39	951.67	853.79	774.6	629.73	546.39
Tangible Book Value Per Share	4.21	4.09	3.67	3.27	2.81	2.30
Buildings	237.86	237.56	237.1	236.38	180.15	176.81
Machinery	394.91	380.92	359.04	291.82	214.45	204.84
Construction In Progress	61.98	57.06	11.54	86.49	154.59	6.49

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error